Skip to main content
Signal8

Kenney Stephanie

SEC insider (Form 3/4/5 filer). CIK 0002105422. Officer at Atrium Therapeutics, Inc. (RNA). 2 reported Form 4/5 transactions since Sep 2024; latest on Sep 18, 2026. Located in SAN DIEGO, CA.

Companies Kenney Stephanie has filed insider reports for

  • Atrium Therapeutics, Inc. (RNA): Officer, See Remarks
Kenney Stephanie profile photo

Kenney Stephanie

CIK: 0002105422

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Atrium Therapeutics, Inc. logo
RNA

Atrium Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Atrium Therapeutics, Inc. logo
    RNA

    Atrium Therapeutics, Inc.

    Sep 18, 2026
    Tax Payment
    Direct
    2.4K shares at avg. $8.95$21K
  • Atrium Therapeutics, Inc. logo
    RNA

    Atrium Therapeutics, Inc.

    Apr 20, 2026
    Award
    Direct
    30K shares-

1-2 of 2